Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimers disease are treated. Using a stepwise development approach, the Company is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4-associated Alzheimers disease programs. Its pipeline consists of candidates targeting patient populations. Its most advanced cardiovascular product candidate, LX2006 for the treatment of patients with Friedreichs ataxia (FA), cardiomyopathy, is being evaluated in SUNRISE-FA, an ongoing Phase I/II clinical trial. Its second most advanced cardiovascular product candidate, LX2020 for the treatment of arrhythmogenic cardiomyopathy, caused by mutations in the PKP2 gene (PKP2-ACM), received IND clearance from the United States Food and Drug Administration (FDA).
Find out what a historical investment in LEXEO THERAPEUTICS would be worth today using our LXEO stock calculator.
Buying LXEO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in LEXEO THERAPEUTICS in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in LXEO
What is the ticker symbol of LEXEO THERAPEUTICS?
The ticker symbol for LEXEO THERAPEUTICS is LXEO.
How much is one share of LXEO?
One share of LXEO is valued at $2.95 as of 20 November 2026.
What is the market capitalisation of LEXEO THERAPEUTICS LXEO?
As of 20 November 2026 LEXEO THERAPEUTICS has a market cap of $244.23M.
What is the 52-week high for LEXEO THERAPEUTICS stock?
The LEXEO THERAPEUTICS 52-week high stock price is $10.99.
What is the 52-week low for LEXEO THERAPEUTICS stock?
The LEXEO THERAPEUTICS 52-week low stock price is $2.55.
Can I buy LXEO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LXEO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LXEO on Stake
Buy LXEO from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of LXEO from only US$10 with fractional shares